본문바로가기
HOME>Company>History

History

Company History 1966~2012

2010년대

Company history 2010~
2018 SK bioscience starts phase 1 clinical trials in the U.S. for the next generation pneumococcal vaccine with Sanofi Pasteur

SK Plasma opens new Andong plant

Split off of vaccine business sector, “SK bioscience” launched

“SKY Varicella Inj.,” chickenpox vaccine obtained marketing approval

Merger of SK Petrochemical
2017 Launched SK discovery, a holding company

“Skyzoster,” shingles vaccine was approved for the second time in the world and for the first time in Korea

Received IR52 Jang Young-sil Award for biocopolyester / ABS composite material for automobile interior materials

Signed joint development and production contract for next-generation rotavirus vaccine with PATH, an international NPO organization

Expanded operation of PETG No. 3

SKYFLEX acquired product certification (DNV-GL) for wind power

First application of automobile PCT connector in domestic large and medium sized automobiles

AFSTYLA, hemophilia treatment drug approved in Europe, Australia (April), Japan for the first time for a domestic bio new drug
2016 Launched “SKYCellflu Quadrivalent,” the world's first quadrivalent cell culture influenza vaccine

DMT production facility expansion (Capa-up)

AFSTYLA, hemophilia treatment drug approved to be marketed in the U.S. and Canada (December) for the first time for a domestic bio new drug

Construction of Dongtan Molding Processing Lab (before expansion)

Developed high-performance secondary battery electrolyte additive for the first time in Korea
2015 World's first approved cell culture quadrivalent influenza vaccine item

#1 in 2015 DJSI Korea Chemical sector

Hemophilia treatment NBP601 - US (FDA), EU (EMA) application for marketing approval

Launched “SKYCellflu®,” Korea's first cell culture influenza vaccine

Division of blood product business and establishment of SK Plasma, a subsidiary

2014 Won the Presidential Citation for Job Creation Merit Government Award

Awarded with 2014 K Pharma Night Innovative Pharmaceutical Company Award

Global Standard Management Award (Grand Prize in sustainability report sector)

Signed PPS supply and joint marketing contract with Initz and A. Schulman

Acquired L HOUSE KGMP

Signed contract for development and supply of Sanofi Pasteur and next-generation pneumonia vaccine

Ansan Plant integrated with S House
2013 Awarded the Minister Award and selected as Korea's Top 10 New Technologies in PCT material

Acquired L HOUSE LEED certification GOLD grade (first among global pharmaceutical plants)

Establishment of Teijin and Initz, a joint venture, and construction of PPS facility

ECOZEN, an eco-friendly material, and SKYGREEN acquired Korea's first “Gold Level” certification
2012 Hemophilia treatment, NBP601 selected as Korea's Top 10 New Technologies / won Ministry of Knowledge Economy Award

SID710 EU, patch type dementia treatment, entered the EU market
2011 Launched the world's first film-type erectile dysfunction treatment “Mvix S®”

Won Grand Prize in Green Management sector of the Global Standard Management Award

New Pangyo headquarters, Eco Lab Green Building certification (LEED Platinum certification) / Won Korean Architectural Culture Award

ECOZEN®, world's first eco-friendly high heat-resistant transparent bioplastic - acquired FDA certification

Groundbreaking ceremony for Andong L House, a state-of-the-art vaccine factory

CDP Special Award
2010 ECOZEN®, world's first eco-friendly high heat-resistant transparent bioplastic - acquired FDA certification

Biodiesel Green Technology Grand Prize Minister Award

Acquisition of shares and merger with SK NJC investment company

Company history 2000~2009

Company history 2000~2009
2009 Development of “ECOZEN®,” eco-friendly transparent heat-resistant copolyester

Establishment of SK Syntec

L/O of hemophilia treatment NBP601 for the first time for a Korean bio new drug

Establishment of ST Green Energy
2008 L/O of dementia treatment patch 'SID710' for the first time for a Korean incrementally modified drug

Establishment of SK Chemicals GmbH (German Frankfurt corporation)

Acquired UB Care, a healthcare solution specialized company
2007 In2Gen merger

Launched “Mvix,” a new drug for treating erectile dysfunction

Establishment of Shanghai Branch of SK Pharma Beijing Co., Ltd.
2006 Dongshin Pharmaceutical was merged with SK Chemicals

Development of biodiesel production technology
2005 Establishment of SK Pharma Beijing Co., Ltd. (local invested subsidiary in China)

Establishment of SK Chemicals Suzhou Co., Ltd. (local invested subsidiary in China)

Establishment of SK Petrochemical (physical division of petrochemical business PTA/DMT sector)

Establishment of SK Utis

SK Pharmaceutical was acquired by SK Chemicals
2002 Establishment of SK Eurochem (local invested subsidiary in Poland)

Launched “Joins,” Korea's natural new No. 1 drug for arthritis
2001 Establishment of SK Chemicals (Qingdao) Co., Ltd. (local invested subsidiary in China)

Development of “SKYGREEN,” an eco-friendly high functional resin
2000 Split off of polyester fiber business sector, the establishment of joint venture HUVIS

Company history 1990~1999

Company history 1990~1999
1999 Omed, a gastric ulcer drug, was exported to the EU for the first time for a Korean finished drug product

Korea's new drug No. 1, the world's first 3rd generation platinum complex anticancer drug “Sunpla” was launched
1998 Establishment of SK NJC

The company name was changed from Sunkyung Industries to SK Chemicals
1994 Development of Trast®, anti-inflammatory patch

Development of polyester adhesive
1991 Establishment of SK Keris (local invested subsidiary in Indonesia)

Development of Ginexin F, a ginkgo leaf blood circulation improvement drug
1990 Establishment of Petrochemical Research Center

The company name was changed from Sunbo Pharmaceutical to Sunkyung Pharmaceutical

Company history 1980~1989

Company history 1980~1989
1989 Completed emulsified PTA (Pure Terephthalic Acid)/DMT (Dimethylterephthalate) plant

Establishment of Life Science Research Center

Development of Polyphenylene sulfide (PPS) resin
1988 The company name was changed to Sunkyung Industries
1987 Establishment of Sunbo Pharmaceutical

Acquires Samshin Pharmaceutical

Establishment of SK CYTEC
1985 Sunkyung Co., Ltd. acquired Suwon Textile Factory
1984 Construction of Sunkyung Synthetic Fiber Research Institute in Suwon Plant

Company history 1960~1978

Company history 1969~1978
1978 Developed polyethylene terephthalate (PET) resin for bottles for the first time in Korea
1976 Initial Public Offering

Sunkyung Synthetic Fiber absorbed with Sunkyung Chemical Fiber
1969 Establishment of Sunkyung Synthetic Fiber Co., Ltd.